Vascular smooth muscle cell migration, proliferation, and differentiation are central to blood vessel development. Since neointimal formation after vascular injury may require the reexpression of a smooth muscle developmental sequence, we examined the expression of H19, a developmentally regulated gene, in rat blood vessels. Expression of the H19 gene is associated with the differentiation process that takes place during development of many tissues. Consistent with this, H19 was highly expressed in the 1-d-old rat aorta but was undetectable in the adult. H19 transcripts were only minimally detected in uninjured carotid artery but were abundant at 7 and 14 d after injury and were localized by in situ hybridization, primarily to the neointima. H19 transcript were undetectable in proliferating neointimal cells in culture but became highly abundant in postconfluent, differentiated neointimal cells. H19 transcripts were only minimally expressed in adult medial smooth muscle cells grown under the identical conditions. Thus, H19 may play an important role in the normal development and differentiation of the blood vessel and in the phenotypic changes of the smooth muscle cells, which are associated with neointimal lesion formation. The vascular injury model may be a useful system to use in examining the function of H19. (J. Clin. Invest. 1994. 93:355-360.)
Introduction
The pathophysiologic growth of vascular smooth muscle cell (VSMC),' which plays a central role in the development of various vascular diseases such as neointimal development, is accompanied by a switch in phenotype of the cells towards a neonatal or embryonic genetic program ( 1 ) . Many ofthe phenotypic markers that are reexpressed in the growing VSMCs are constituents of the contractile apparatus (2) , the paracrine growth factors (3), or the extracellular matrix (3, 4) , and are presumably important to the growth characteristics ofthe cells.
However, the expression of many of these proteins is probably secondary to the primary events that mediate cell growth and differentiation. While genes important in the development and differentiation of skeletal muscle cells have been isolated (5) , no genes with similar functions have been identified for vascular VSMC.
H 19 is a developmentally regulated gene whose expression peaks during fetal development when tissue differentiation is occurring (6) . It is highly expressed in mouse embryonic tissue of endodermal and mesodermal origin and is dramatically downregulated after birth (7) . At present, the function of Hl 9 gene is unknown. However, the overexpression of the H19 gene in transgenic mice caused prenatal lethality iW the late portion of the gestational period (8) . H 19 gene has been independently isolated by several investigators interested in genes activated during myoblast differentiation (Myo H) (5) and during embryonal carcinoma cell differentiation (9). These observations suggest that H 19 has a crucial role in cellular development and differentiation.
The regulation ofH 19 gene expression in blood vessel development and neointimal formation is unclear. Han and Liau ( 10), using differential screening, have isolated a cDNA from a rabbit fetal aortic smooth muscle cell library that exhibits 73% homology to the human H 19 cDNA, which they termed F-3 1. However, in the rabbit, F-3 1 does not show the same pattern of expression observed for H 19 in other species. For example, while H 19 is expressed in the heart and skeletal muscle of the adult rat, F-3 1 is not expressed in the rabbit heart and is only weakly expressed in the rabbit skeletal muscle. Thus, at this point, it is not known ifF-3 1 To study developing vessels, aortae were harvested from neonatal rats at various times after birth.
Cell isolation and culture. 14 d after balloon injury the left (injured) and right (uninjured) carotid arteries were removed for isolation of VSMCs by a modification of the method of Owens et al ( 1) . Vessels were stripped of loose perivascular connective tissues and placed in an enzyme dissociation mixture consisting of Waymouth's Ml 3 752/1 medium (Gibco BRL, Gaithersburg, MD); 1 mg/ml type 2 collagenase, Biochemical Co., 0.25 mg/ml elastase, and 1 mg/ml soybean trypsin inhibitor (each from Worthington Biochemical Co., Freehold, NJ); 2 mg/ml BCA (fraction V; Sigma Chemical Co., St. Louis, MO) at 370C for 10 min. This procedure facilitated dissection ofthe adventitia, media, and neointima. Under a dissecting microscope, vessels were opened longitudinally. To obtain control medial VSMCs from the uninjured right carotid artery, endothelial cells were first removed by gentle scraping using forceps. Medial tissue was stripped and cut into small pieces. To obtain neointimal VSMCs from the injured left carotid artery, the neointimal layer was first stripped, using fine forceps, and treated as above for the medial VSMCs. The isolation ofthe neointimal region was confirmed by hematoxylin and eosin staining of stripped vessel (data not shown). The dissected media and neointima were incubated in the same enzyme dissociation mixture (see above) at 370C for 60 min in a gyratory shaker. Cells were titurated every 30 min. After adding 20% FBS (Gibco BRL) to inactivate the enzymes, the cell suspension was filtered through a sterile gauze to remove undigested tissue. The cells were centrifuged (200 g, 5 min) and resuspended in Waymouth's medium supplemented with 10% FBS, 100 mg/ml penicillin, and 0.1 mg/ml streptomycin (Gibco BRL) and plated on a 25-cm tissue culture flask (Falcon Plastics, Oxnard, CA), with a density of 2-5 X 103 cells/cm2. The cells were incubated at 37°C in a humidified 5% C02-95% air atmosphere. The culture medium was changed after 18-24 h and then routinely changed at 48-72-h intervals thereafter.
Both neointimal and control medial VSMCs stained positively for alpha-smooth muscle actin as determined by immunohistochemistry using a specific mAb (Sigma Chemical Co.).
Cells were routinely passaged at a 1:3 to 1:5 ratio and studied between passages 5 and 8. Preconfluent cells were harvested at 60-70% confluence. Confluent cells were harvested when VSMCs had reached 100% confluence. At confluence, the cells were made quiescent by incubation for 72 h in a defined serum-free (DSF) medium containing insulin (5 x I0 -M), transferrin (5 mg/ml), and ascorbate (0.2 mM). This growth condition maintains VSMCs in a quiescent, noncatabolic differentiated state and promotes the expression ofVSMC-specific proteins ( 11) .
RNA isolation. Frozen samples ofthe aorta and the carotid arteries were homogenized in guanidine isothiocyanate. Total RNA was isolated by centrifugation through a cesium chloride solution ( 12) Reverse transcription-polymerase chain reaction (R T-PCR) and probe construction. Based on the homologous nucleotide sequence between the human and mouse H 19 cDNA sequence (6, 9), two oligonucleotide primers for PCR were prepared (sense; 5'-AGGGCCCAC-AGTGGACTTGG-3', antisense; 5'-TCACACCGGACCATGTCA-TGT-3'), which cover 395 base pairs (nucleotide sequence 582-976) of the mouse H 19 cDNA. After reverse transcription of 100 ng oftotal RNA by oligo(dT) priming the resulting single stranded cDNA was subjected to PCR using the GeneAmp RNA PCR kit (Perkin-Elmer Cetus, Norwalk, CT). Each PCR cycle consisted ofa denaturation step (950C, I min), an annealing step (60'C, 2 min), and an elongation step (720C, 3 min). The PCR products were resolved on the 1.5% agarose gel. PCR analysis of each sample was repeated at least three times.
The PCR-amplified fragment was subcloned into pCRII vector (Invitrogen Corp., La Jolla, CA), generating pCRH19-4. Specificity of the PCR amplification was checked by sequencing (data not shown). For Northern blot analysis, the cloned inserts from pCRH 19-4 were isolated and radiolabeled with [32p] dCTP by a random primer labeling (Gibco BRL).
Northern blot analysis. 20 mg oftotal RNA was electrophoresed on 1% denaturing formaldehyde agarose gel, containing ethidium bromide as described ( 12) . The gels were examined under UV to demonstrate equal loading. RNA samples were transferred onto nylon membrane (Genescreen, New England Nuclear, Boston, MA) and then hybridized to a rat H19 cDNA probe ( 106 cpm/ml). Filters were washed two times (5 min each) in 0.5X SSC ( lX SSC = 0.15 M NaCl, 15 mM sodium citrate), 0.1% SDS at room temperature, then three times (30 min each) in 0.2x SSC, 0.1% SDS at 560C. Autoradiography was performed for 2 d, using Kodak XAR-5 film with intensifying screens at -700C.
In situ hybridization. 14 d after balloon injury, rats were anesthetized with ether and perfused at physiological pressure ( 110 mm Hg) through the left ventricle with 100 ml PBS, pH 7.2, followed by 80 ml of freshly prepared 4% paraformaldehyde. After removal ofthe carotid artery, postfixation was performed with the same fixative as described above at 4°C for 4. h, after which the tissue was embedded in paraffin. Injured and control uninjured vessels were placed side by side in one block. 6-am sections were cut and placed on 3-amino-propyltriethoxysilane (Sigma Chemical Co.) coated glass slides. "S-labeled antisense and sense complementary RNA were generated as previously described (12) from pCRH19-4, using the Riboprobe Gemini II core system (Promega Corp., Madison, WI). In situ hybridization was performed using the in situ hybridization system (Oncor, Gaithersburg, MD), according to the manufacturer's instructions, using a 106 cpm/ml probe. After final washing, dehydrated slides were dipped in diluted photographic emulsion (NTB-2, Eastman Kodak Co.), and exposed for 2 wk at 4°C. The slides were developed and fixed, counterstained with hematoxylin and eosin, examined on a microscope, and photographed.
Results
The expression of H 19 during ontogeny exhibits tissue specific regulation (5-9). Therefore, we investigated H 19 gene expression during blood vessel development. Using RT-PCR technique, the PCR amplification products were examined after 25, 30, 35, or 40 cycles. Little or no amplification product was observed when RNA from adult aorta was used as a template. In contrast, a strong signal was detected when RNA from the l-d-old pup aorta was used (Fig. 1 A) . In order to examine the time course of H19 mRNA expression after birth, Northern blotting analysis was performed (Fig. 1 B) . Northern analysis of rat aortic RNA demonstrated the presence of the specific 2.3-kb H19 mRNA transcript. In the developing aorta, H19 mRNA was higher in l-d-old aorta, then decreased progressively in the l-wk-and 2-wk-old aorta. H 19 mRNA was barely detectable in 12-wk-old adult aorta. Thus, H 19 expression is developmentally regulated in the developing vessels of the rat.
Next, we investigated expression of H 19 after vascular injury. Using RT-PCR, RNA from the injured vessels showed a strong signal compared to that of the uninjured vessels (Fig. 2   A) . Northern blot analysis showed that H19 gene expression was very weak 3 d after balloon injury but increased progressively over the next 4 d, exhibiting a strong signal at 7 d, and remained at the same intensity 14 B). In contrast, control uninjured right carotid artery contained little, if any, H 19 mRNA.
To localize H 19 mRNA expression within the vessel wall, we performed in situ hybridization analysis. Emulsion autoradiography of sections hybridized to a 35S-labeled rat H 19 antisense RNA probe demonstrated that hybridization signal was abundant in the neointima, but low or absent in the underlying media, 14 d after balloon injury (Fig. 3 A) or in the media of uninjured vessel (Fig. 3 C) . The control sense probe showed only rare grains indicating minimal nonspecific binding (Fig. 3  BandD) .
Since H 19 gene is reexpressed after vascular injury, it was of interest to examine whether the expression of this gene could be regulated in cultured neointimal cells. We cultured vascular smooth muscle cells from the neointima ofa carotid artery that was balloon injured 14 d earlier. Control medial VSMCs were isolated from uninjured carotid arteries. In subconfluent conditions, the two cultures appeared morphologically similar and both stained positively for alpha-smooth muscle actin (Fig. 4 A and B). At confluence, the cultured medial VSMC exhibited the typical morphology of adult VSMC showing multilayered, spindle-shaped "hill and valley" appearance (Fig. 4 C) . However, cultured neointimal cells exhibited a strikingly different morphology (Fig. 4 D) . Similar to the results reported by Walker et al. ( 13), we observed that neointimal smooth muscle cells remained monolayered after confluence and retained a polygonal "epitheliod" morphology. This epitheliod appearance is similar to that observed for neonatal rat ( 14) and rabbit ( 10) smooth muscle cells. Both cell cultures were contact inhibited under confluent conditions (data not shown). RNA was harvested from proliferating preconfluent cells, confluent cells, and 3-d postconfluent cells grown in a DSF medium. The RNA was then analyzed by Northern blotting (Fig. 5) (lanes 3, 6) . The RNA was analyzed by Northern blotting.
response to injury, and attempts to gain insight into its role in vascular smooth muscle growth and differentiation. First, the results indicate that, as in most tissues, the expression ofH 19 in the blood vessel decreases dramatically after birth, becoming nearly undetectable in the adult animal. This is in sharp contrast to the expression in other muscle tissues, such as cardiac and skeletal muscle, where the expression ofH 19 persists in the adult animal. Secondly, these results support the notion that the vascular response to injury is accompanied by a reexpression of earlier developmental events. Third, we also showed that such phenotypic differences can be maintained in an in vitro culture system and that the expression of H 19 in culture can be regulated.
Restenosis is a significant clinical problem in cardiovascular medicine that limits the long-term success ofinterventional therapy (e.g., angioplasty) for coronary and peripheral vascular disease ( 15, 16) . The restenotic lesion is fibroproliferative in nature and consists of fibroblasts, VSMCs, and macrophage/foam cells ( 17, 18) . Among the many animal models for the studies of lesion formation, the balloon-injured rat carotid artery is one of the most widely employed ( 19, (20) (21) (22) . The molecular and cellular processes that contribute to the rat lesion formation have been investigated and involve proliferation of "activated" medial VSMCs, migration of the VSMCs into the intima, and further proliferation to form the neointima (23, 24). The neointimal VSMCs are phenotypically distinct from the medial VSMCs, since the neointimal cells express a subset ofthe proteins normally expressed in the embryonic or neonatal VSMCs (2) (3) (4) . The data are consistent with two distinct hypotheses (1); (a) outgrowth of dedifferentiated medial VSMC (2) or (b) the presence within the normal media ofan undifferentiated stem cell (25, 26 ) that responds to vascular injury with proliferation and migration. However, the differential phenotype ofthe neointima is not completely "neonatal" (27) nor is it stable. The growing neointimal VSMCs still express certain adult specific characteristics and at later times after injury (2, 28) , when the rate of growth of the neointima decreases, the expression of the adult phenotype increases.
H19 Was originally cloned in a search for genes that are downregulated after birth. Attempts to use transgenic techniques to investigate the function of this gene have resulted in prenatal lethality at or around day 14 ofgestation (8 ( 11 ) have shown that exponentially growing VSMCs exhibit a phenotype different from confluent, quiescent smooth muscle, with the former expressing nonmuscle isoforms ofvarious contractile proteins. After reaching confluence, the expression ofthese proteins is suppressed while the expression of muscle isoforms is increased, presumably indicating a differentiation process. While the studies by Owens and co-workers ( 11 ) were performed with adult aortic smooth muscle cells, it is reasonable to assume a similar event may take place as the neointimal cells become growth arrested. This suggests that the expression of H 19 is a marker for and perhaps a mediator of VSMC differentiation and/or growth arrest. This is consistent with other reports on the expression of H 19. For example, Wiles et al. (9) found that the gene is silent in undifferentiated embryonal carcinoma cells and becomes expressed when these cells are induced to differentiate into endoderm.
Similarly, in C3H lOT 1/2 cells, a multipotential mesodermal embryonic cell line that can mimic different stages in muscle cell development, there was a dramatic increase in H 19 gene expression upon determination of the precursor stem cells to myoblast (6) . It should be pointed out that the expression of H 19 is not a universal characteristic of growth-arrested cells. For example, Davis et al. (5) showed that confluent, quiescent Swiss 3T3 cells do not express H 19.
The expression and regulation of H 19 in these cultures differs from that reported by Han and Liau (10) for F-31 in rabbit smooth muscle cell cultures. F-3 1 was not detectable in adult rabbit smooth muscle cells, whereas H 19 was found, albeit at low levels, in postconfluent adult rat smooth muscle cells (Fig. 5) . In rabbit neonatal cells, F-31 was observed in proliferating neonatal cells but not in postconfluent cells. In contrast, in the rat neointimal cells, which are phenotypically similar to the neonatal smooth muscle cells ( 13, 14) , H 19 was not observed in proliferating cells but became abundant in the HI 9 Gene Expression after Vascular Injury postconfluent cells. These results, plus the different pattern of expression of H 19 and F-3 1 in adult heart and skeletal muscle, suggests that these two genes are not homologues but may represent distinct genes. However, this point requires further investigation.
Considering H 19 as a marker of VSMC differentiation and perhaps growth arrest, the expression of H 19 in the neointima may suggest that these cells are undergoing differentiation. This is consistent with biochemical and immunocytochemical studies on the expression of contractile and cytoskeletal proteins after vascular injury, which showed an early de-differentiation after injury, followed by a partial re-differentiation (2) . Our finding that the expression of H 19 already reached a plateau 7 d after vascular injury may suggest that the re-differentiation process starts early during the evolution of neointimal formation. 
